Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 10/1/15 All times are local (Market data is delayed by at least 15 minutes).

atheronova inc (AHROQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/23/14 - $2.00
52 Week Low
06/11/15 - $0.0050
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ATHERONOVA INC (AHROQ)

atheronova inc (AHROQ) Related Bloomberg News

View More Bloomberg News

atheronova inc (AHROQ) Related Businessweek News

No Related Businessweek News Found

atheronova inc (AHROQ) Details

AtheroNova Inc., a development stage company, is engaged in the research, development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. The company develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. Its lead compound includes AHRO-001, an active pharmaceutical ingredient. The company also focuses on developing various applications for its patented and patents-pending therapies in market sectors that comprise cardiovascular disease, stroke, and peripheral artery disease. AtheroNova Inc. was founded in 2006 and is based in Irvine, California. On March 2, 2015, AtheroNova Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Central District Of California. It is in joint administration with AtheroNova Operations, Inc.

3 Employees
Last Reported Date: 10/29/14
Founded in 2006

atheronova inc (AHROQ) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: --
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $168.0K
Compensation as of Fiscal Year 2013.

atheronova inc (AHROQ) Key Developments

AtheroNova Inc. will Change its Ticker to AHRO.Q from AHRO

Effective March 04, 2015, AtheroNova Inc. will change its Pink Sheets LLC stock ticker symbol to AHRO.Q from AHRO.

AtheroNova To Sell Assets Under Chapter 11

AtheroNova Inc. (OTCPK:AHRO) and AtheroNova Operations, Inc. filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court on March 2, 2015. AtheroNova will evaluate all options, including a Bankruptcy Court supervised asset sale process, for all or substantially all of its assets to a party who could potentially be interested in continuing its clinical programs.

AtheroNova Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015

AtheroNova Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 . Venue: Westin St. Francis Hotel, San Francisco, California, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AHROQ:US $0.01 USD 0.00

AHROQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AHROQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation AHROQ Industry Range
No financial data is available for AHROQ.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERONOVA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at